This is an advertisement
Contact us for a free legal consultation.
Tenofovir disoproxil fumarate (TDF) drugs, like Truvada, Viread, Atripla, Complera, and Stribild, are linked to an increased risk of kidney disease and bone fractures.
Onglyza is linked to an increased risk of heart failure, heart attack, cardiovascular injury, and even death.
Testosterone therapy has been aggressively marketed to men who suffer from "Low T," a vague condition that has little scientific basis.
Abilify is used to treat depression, bipolar disorder, and schizophrenia. But evidence suggests that the drug can cause compulsive behaviors like gambling.
The diabetes drug Invokana has been linked to diabetic ketoacidosis (DKA), kidney problems, pancreatitis, cardiovascular risks, and bone fractures.
Merck & Co. faces lawsuits over its shingles vaccine Zostavax, which plaintiffs allege can cause severe side effects like blindness and paralysis.
Type 2 diabetes drug Byetta is linked to an increased risk of pancreatic cancer in patients, but the drug's label does not warn about this side effect.
Xarelto is marketed as being easier to use than warfarin. But Bayer's ads failed to mention that Xarelto can cause uncontrolled, irreversible bleeding.
Victoza, a type 2 diabetes drug, may cause pancreatic cancer. Manufacturer Novo Nordisk faces lawsuits for allegedly failing to warn patients and doctors about this risk.
The blood thinner Pradaxa did not have an antidote for its bleeding events until 2015, leading to hundreds of casualties.
Patients taking type 2 diabetes drug Kombiglyze XR may have a greater risk of heart failure. AstraZeneca is now battling lawsuits alleging they failed to warn of this risk.
Temporary hair loss is common during chemotherapy, but permanent hair loss may be more common with Taxotere than with other types of chemo drugs.
Empowering the People. Holding Companies Accountable.